Binge-eating disorder
Conditions
Interventions
This is a single blind randomized controlled trial. Experimental intervention: 60 people with binge eating disorder and overweight/obesity will be submitted to 15 sessions of online group multidiscipl
F04.754.137.350
G11.427.410.698.277
SP6.180.632.655
Sponsors
Faculdade de Medicina da Universidade de São Paulo
Faculdade de Medicina da Universidade de São Paulo
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age greater than or equal to 18 years; binge eating disorder according to DSM-5 criteria; body mass index between 27 and 45 kgm2; able to read and write; access to a computer with internet; access to a private room to participate in the online therapy sessions; and access to a scale and stadiometer to measure body weight and height
Exclusion criteria
Exclusion criteria: Bariatric surgery in the previous 24 months; currently receiving any other treatment for weight loss/binge eating; clinical conditions that interfere with weight control e.g., Prader-Willi Syndrome, Cushing Syndrome; being pregnant; and severe psychiatric disorder i.e., schizophrenia, bipolar disorder or a high suicide risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect statistically significant reductions in eating disorder symptoms, such as binge eating episodes, measured with the Eating Disorder Examination Questionnaire and Loss of Control over Eating Scale at pre- and post-treatment. We expect this outcome on the experimental intervention and control intervention.;We expect to find statistically significant reductions in body weight, measured via self-report, at pos-treatment in comparison to pre-treatment only in participants submitted to the experimental intervention (multidisciplinary treatment). | — |
Secondary
| Measure | Time frame |
|---|---|
| We expect to find statistically significant reductions in symptoms of depression, anxiety, and stress, measured via the Depression Anxiety and Stress Scale, at pos-treatment in comparison to pre-treatment. We expect this outcome on the experimental intervention and control intervention.;We expect to find statistically significant improvement in quality of life, measured with the 12-Item Health Survey (SF-12), at pos-treatment in comparison to pre-treatment. We expect this outcome on the experimental intervention and control intervention.;We expect to find a statistically significant increase in physical activity, measured via a semi structured interview based on the Surveillance of Risk and Protective Factors for Chronic Disease (VIGITEL), at pos-treatment in comparison to pre-treatment only in participants submitted to the experimental intervention (multidisciplinary treatment).;We expect to find a statistically significant increase in mindful eating, measured with the Mindful Eating Scale, at pos-treatment in comparison to pre-treatment only in participants submitted to the experimental intervention (multidisciplinary treatment).;We expect to find statistically significant improvement in quality of sleep, measured with the Pittsburgh Sleep Quality Index, at pos-treatment in comparison to pre-treatment. We expect this outcome on the experimental intervention and control intervention.;We expect to find statistically significant reduction in difficulties with emotion regulation, measured with the Difficulties in Emotion Regulation Scale, at pos-treatment in comparison to pre-treatment. We expect this outcome on the experimental intervention and control intervention.;We expect to find statistically significant reduction in body checking and avoidance, measured with the Body Checking and Avoidance Questionnaire, at pos-treatment in comparison to pre-treatment. We expect this outcome on the experimental intervention and control intervention. | — |
Countries
Brazil
Contacts
Public ContactFelipe Quinto da Luz
Faculdade de Medicina da Universidade de São Paulo
Outcome results
None listed